The past five years for Estia Health (ASX:EHE) investors has not been profitable




  • In Business
  • 2022-09-28 01:37:04Z
  • By Simply Wall St.
 

For many, the main point of investing is to generate higher returns than the overall market. But every investor is virtually certain to have both over-performing and under-performing stocks. So we wouldn't blame long term Estia Health Limited (ASX:EHE) shareholders for doubting their decision to hold, with the stock down 38% over a half decade.

Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns.

See our latest analysis for Estia Health

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

In the last half decade Estia Health saw its share price fall as its EPS declined below zero. Since the company has fallen to a loss making position, it's hard to compare the change in EPS with the share price change. However, we can say we'd expect to see a falling share price in this scenario.

The image below shows how EPS has tracked over time (if you click on the image you can see greater detail).

Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here.

What About Dividends?

When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. As it happens, Estia Health's TSR for the last 5 years was -28%, which exceeds the share price return mentioned earlier. And there's no prize for guessing that the dividend payments largely explain the divergence!

A Different Perspective

While the broader market lost about 6.9% in the twelve months, Estia Health shareholders did even worse, losing 15% (even including dividends). Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 5% over the last half decade. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. You could get a better understanding of Estia Health's growth by checking out this more detailed historical graph of earnings, revenue and cash flow.

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on AU exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You'll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here

COMMENTS

More Related News

Those who invested in Beach Energy (ASX:BPT) five years ago are up 61%
Those who invested in Beach Energy (ASX:BPT) five years ago are up 61%

Stock pickers are generally looking for stocks that will outperform the broader market. Buying under-rated businesses...

Pact Group Holdings (ASX:PGH) investors are sitting on a loss of 78% if they invested five years ago
Pact Group Holdings (ASX:PGH) investors are sitting on a loss of 78% if they invested five years ago

We're definitely into long term investing, but some companies are simply bad investments over any time frame. We don't...

Cameco (TSE:CCO) shareholders have earned a 23% CAGR over the last five years
Cameco (TSE:CCO) shareholders have earned a 23% CAGR over the last five years

While Cameco Corporation ( TSE:CCO ) shareholders are probably generally happy, the stock hasn't had particularly good...

CTS
CTS' (NYSE:CTS) investors will be pleased with their respectable 60% return over the last five years

When we invest, we're generally looking for stocks that outperform the market average. And in our experience, buying...

Globe Life
Globe Life's (NYSE:GL) five-year earnings growth trails the 6.7% YoY shareholder returns

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business